1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1) (
- Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial (
- 2017
- Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma (
- Vaccination and allergy : EAACI position paper, practical aspects (
- 2016
- Regulation of the germinal center response by T follicular helper cells and type I interferons (
- 2015
- Tamoxifen treated patients have a better survival than patients treated with aromatase inhibitors - A population based registry study in Sweden (
- 2012
- Adjuvant therapy in primary GIST: state-of-the-art (
- 2008
- Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. (
- 2007
- Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy (
- 2006
- Abdominal & pelvic radiotherapy: acute effects on inflammation, leucocytes and collagen deposition (